OSR Health (OSRHW) Profit After Tax (QoQ) (2022 - 2026)
OSR Health (OSRHW) Profit After Tax (QoQ) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.97 Bn | 131.12 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.15 Bn | 77.15 Bn | 3.93 Bn |
| 3 | Argenx Se | 62.84 Bn | 57.65 Bn | 1.37 Bn |
| 4 | Moderna | 55.74 Bn | 50.60 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.53 Bn | 36.43 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.32 Bn | 8.93 Bn | 668.28 Mn |
| 8 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - |
| 9 | Insmed | 26.99 Bn | 25.83 Bn | 358.27 Mn |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -135.09% |
| Dec 31, 2025 | 372.28% |
| Sep 30, 2025 | 30.54% |
| Jun 30, 2025 | 52.18% |
| Mar 31, 2025 | -732.30% |
| Dec 31, 2024 | 60.89% |
| Sep 30, 2024 | -48.13% |
| Jun 30, 2024 | 32.47% |
| Mar 31, 2024 | -344.46% |
| Dec 31, 2023 | 1,655.61% |
| Sep 30, 2023 | -74.07% |
| Jun 30, 2023 | 173.30% |
| Mar 31, 2023 | 873.96% |
| Dec 31, 2022 | 28.82% |
| Sep 30, 2022 | -1,926.52% |